Intellectual property (IP) rights have been the driving force behind innovation and entrepreneurship. However, IP has more recently been seen in a negative light.


Through the COVID-19 Pandemic, vaccine IP rights have come into question: should IP rights be waived when concerning an essential technology?


Andrei Iancu, Former Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, joins the podcast to discuss his views and concerns on IP rights:


What we talked about:
- The Benefits of IP
- How Sentiment of IP Has Changed
- Short, Medium, & Long Term Concerns to Waiving IP Rights
- Where Concerns Should Be Focused & How to Improve IP


Check out the resources below for more information:
- Andrei’s LinkedIn
- Our host: John Stanford’s LinkedIn
- www.incubatecoalition.com

To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

The fight against Antimicrobial Resistance (AMR) is challenging due to financial, ethical, and legislative issues. Combating infectious disease can prove to be a risky financial investment but much less in comparison to the global impact if solutions are not researched.


Alfonso Chang is the Managing Director of Relativity Healthcare Partners; he shares insight into the challenges and how to overcome them:
- Investor Hesitancy

- Higher clinical and ethical implications

- Preference of existing therapies over new ones

- Unintended consequences from lawmakers due to drafted legislative language


Check out the resources below for more information:

- Alfonso’s LinkedIn

- Our host: John Stanford’s LinkedIn


To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

In 1980, the Bayh-Dole Act was enacted by U.S. Congress, which changed how ownership of an invention is pursued. Almost 40 years later, how has this act fared?

On Episode 1 of Making Medicine, John Stanford, Executive Director of Incubate Coalition, introduces Joseph Allen and Associates to cover:

- How Bayh-Dole came to be, starting with Purdue University

- The original intent of ‘march-in’ rights and how it affects Bayh-Dole

- Who was this act for, and how has it played out 40 years later?

As we begin on this new journey together, we would love to hear from you, the listener. Email [email protected] or [email protected] what’s top of mind, what story you want to hear, or what you find interesting!

To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.

From chance meetings to risky investments, Making Medicine explores the origin stories of life changing medication and how patients, corporations and investment communities benefit from understanding it.

On today’s episode, Kelsey Kohrs, Producer at Sweet Fish Media and John Stanford, Executive Director of Incubate Coalition introduce Making Medicine, a podcast dedicated to sharing life science stories that have led to scientific breakthroughs. These stories will cover:

- What are the different steps of the drug development process?

- How can we sustain future innovation in the life sciences?

-When chance meetings have led to life changing drug innovation

As we begin on this new journey together, we would love to hear from you, the listener. What’s interesting? What do you want to hear more of? Is there a story that you’ve heard of that you’d like our team to dig in to? Email [email protected] or [email protected].

To hear more interviews like this one, subscribe to Making Medicine on Apple Podcasts, Spotify, or your preferred podcast platform.